Selecting Insulin Analogs for Closed-Loop Control Using Multiplex Pharmacokinetic Profiling
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 09 Feb 2017
At a glance
- Drugs Insulin aspart (Primary) ; Insulin glulisine (Primary) ; Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- 07 Jun 2017 Biomarkers information updated
- 06 Feb 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 06 Sep 2016 Status changed from recruiting to active, no longer recruiting.